These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31418595)

  • 1. Halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate K
    Maravić A; Rončević T; Krce L; Ilić N; Galić B; Čulić Čikeš V; Carev I
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1770-1776. PubMed ID: 31418595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]).
    Ivankovic S; Stojkovic R; Galic Z; Galic B; Ostojic J; Marasovic M; Milos M
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):354-9. PubMed ID: 24939106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of methicillin resistant
    Upreti N; Rayamajhee B; Sherchan SP; Choudhari MK; Banjara MR
    Antimicrob Resist Infect Control; 2018; 7():121. PubMed ID: 30338059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of calcium ion on cytotoxic effect of the boroxine derivative, K
    Ivankovic S; Stojkovic R; Maksimovic M; Galic B; Milos M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):70-74. PubMed ID: 27389366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234.
    Papp-Wallace KM; Nguyen NQ; Jacobs MR; Bethel CR; Barnes MD; Kumar V; Bajaksouzian S; Rudin SD; Rather PN; Bhavsar S; Ravikumar T; Deshpande PK; Patil V; Yeole R; Bhagwat SS; Patel MV; van den Akker F; Bonomo RA
    J Med Chem; 2018 May; 61(9):4067-4086. PubMed ID: 29627985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitizing of β-lactam resistance by tannic acid in methicillin-resistant S. aureus.
    Kırmusaoğlu S
    World J Microbiol Biotechnol; 2019 Mar; 35(4):57. PubMed ID: 30900046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
    Klingler FM; Wichelhaus TA; Frank D; Cuesta-Bernal J; El-Delik J; Müller HF; Sjuts H; Göttig S; Koenigs A; Pos KM; Pogoryelov D; Proschak E
    J Med Chem; 2015 Apr; 58(8):3626-30. PubMed ID: 25815530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial and KPC/AmpC inhibitory activity of functionalized benzosiloxaboroles.
    Durka K; Laudy AE; Charzewski Ł; Urban M; Stępień K; Tyski S; Krzyśko KA; Luliński S
    Eur J Med Chem; 2019 Jun; 171():11-24. PubMed ID: 30904754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria.
    Zhang J; Chen YP; Miller KP; Ganewatta MS; Bam M; Yan Y; Nagarkatti M; Decho AW; Tang C
    J Am Chem Soc; 2014 Apr; 136(13):4873-6. PubMed ID: 24628053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria.
    Ali A; Danishuddin ; Maryam L; Srivastava G; Sharma A; Khan AU
    J Biomol Struct Dyn; 2018 May; 36(7):1806-1821. PubMed ID: 28545327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipotassium-trioxohydroxytetrafluorotriborate, K₂[B₃O₃F₄OH], is a potent inhibitor of human carbonic anhydrases.
    Vullo D; Milos M; Galic B; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):341-4. PubMed ID: 24939103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dipotassium trioxohydroxytetrafluorotriborate (K2[BO3F4OH]) on genetic material and inhibition of cell division in human cell cultures.
    Haveric S; Haveric A; Bajrovic K; Galic B; Maksimovic M
    Drug Chem Toxicol; 2011 Jul; 34(3):250-4. PubMed ID: 21649478
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Monogue ML; Giovagnoli S; Bissantz C; Zampaloni C; Nicolau DP
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 30012751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on β-lactamase inhibitor discovery and development.
    Docquier JD; Mangani S
    Drug Resist Updat; 2018 Jan; 36():13-29. PubMed ID: 29499835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan Derivatives Active against Multidrug-Resistant Bacteria and Pathogenic Fungi: In Vivo Evaluation as Topical Antimicrobials.
    Hoque J; Adhikary U; Yadav V; Samaddar S; Konai MM; Prakash RG; Paramanandham K; Shome BR; Sanyal K; Haldar J
    Mol Pharm; 2016 Oct; 13(10):3578-3589. PubMed ID: 27589087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
    Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM
    PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antimicrobial spectrum of Xeroform
    Barillo DJ; Barillo AR; Korn S; Lam K; Attar PS
    Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling the Antibiotic Resistance Caused by Class A
    Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.